Article Information
PubMed
Print ISSN
Online ISSN
History
- Received November 29, 2016
- Accepted March 8, 2017
- Published online April 14, 2017.
Article Versions
- Earlier version (March 23, 2017 - 08:17).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2017 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license.
Author Information
- AstraZeneca UK Ltd., Cambridge, United Kingdom (E.F.); AstraZeneca Pharmaceuticals LP, Wilmington, Delaware (K.B.); AstraZeneca Pharmaceuticals LP, Gaithersburg, Maryland (M.S.); AstraZeneca Canada, Montreal, Quebec, Canada (K.P.); and Nektar Therapeutics, San Francisco, California, Primary laboratory of origin: AstraZeneca Pharmaceuticals LP, Wilmington, Delaware (M.E.)
- Address correspondence to:
Dr. Khanh Bui, AstraZeneca Pharmaceuticals LP, 35 Gatehouse Dr, Waltham, MA, USA 02451. E-mail: Khanh.Bui{at}astrazeneca.com